April 29, 2022 — Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
April 20, 2022 – Researchers from the RIKEN Center for Advanced Intelligence Project (AIP) and colleagues have tested ...
April 20, 2022 – A new study finds that a history of infertility is associated with increased risk of heart failure ...
April 19, 2022 – New breakthrough research by a University of South Florida lab team describing how certain fats can ...
April 18, 2022 — Eleven teams of scientific researchers have been selected as recipients of American Heart Association r ...
April 15, 2022 — Eleven teams of scientific researchers have been selected as recipients of American Heart Association r ...
April 12, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement ...
April 8, 2022 – Physicians prescribed significantly more guideline-directed medications for heart failure if they ...
April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...
April 7, 2022 – Among patients undergoing non-cardiac surgery who were also on blood pressure medications, a ...
April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...
April 7, 2022 – Patients treated with the blood thinner edoxaban for six months after a heart valve replacement ...
April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...